Skip to main content
RT @RichardPAConway: Wheeler et al. MUC5B assoc risk RA-ILD, OR 2.25. No significant additive interaction with race, smo

Richard Conway RichardPAConway

3 years 10 months ago
Wheeler et al. MUC5B assoc risk RA-ILD, OR 2.25. No significant additive interaction with race, smoking, disease activity @RheumNow #ACR22 Abstr#2250 https://t.co/Hw2oBawKsd https://t.co/DqCQIPpEyg
RT @AkhilSoodMD: Abstr #2195 COVID PrEP in Rheum pts who did not seroconvert after 3rd dose
- anti-SARS-CoV2 IgG levels

Akhil Sood MD AkhilSoodMD

3 years 10 months ago
Abstr #2195 COVID PrEP in Rheum pts who did not seroconvert after 3rd dose - anti-SARS-CoV2 IgG levels ↑ after day 1 - Saliva IgG also ↑ up to day 14 - one reported COVID+ w mild symptoms @RheumNow #ACR22 https://t.co/um2JFNMhpj
RT @RichardPAConway: Zuo @RayZuoMD @jasonsknight et al. High levels of anti-NET antibodies in 45% of aPL-positive patien

Richard Conway RichardPAConway

3 years 10 months ago
Zuo @RayZuoMD @jasonsknight et al. High levels of anti-NET antibodies in 45% of aPL-positive patients May activate the complement cascade and contribute to brain white matter changes. @RheumNow #ACR22 Abstr#2269 https://t.co/JrjNvQRDim https://t.co/c4yXHLOmBJ
RT @Janetbirdope: ILD in #scleroderma. #Scleroderma lung study III - NO DIFF between MMF + Pirfenidone vs MMF alone. Pla

Janet Pope Janetbirdope

3 years 10 months ago
ILD in #scleroderma. #Scleroderma lung study III - NO DIFF between MMF + Pirfenidone vs MMF alone. Planned for 150 Pts but only 51 enrolled but p=0.9. A trial recruited during #COVID so difficult to enroll Abst#530 @RheumNow #ACR22 https://t.co/CBYEJ2YCVM
RT @DrCassySims: How does #COVID19 impact pregnant women with rheumatic disease? Does vaccination status make a differen

Catherine Sims, MD DrCassySims

3 years 10 months ago
How does #COVID19 impact pregnant women with rheumatic disease? Does vaccination status make a difference? @RheumNow #ACR22 https://t.co/2oJ1RAeciN https://t.co/c9s6QRSOR4
RT @Janetbirdope: #Vasculitis #ACR22 highlights. #Rituximab more remission in clinical care for GPA - observational, les

Janet Pope Janetbirdope

3 years 10 months ago
#Vasculitis #ACR22 highlights. #Rituximab more remission in clinical care for GPA - observational, less infections if 600 mg IV fixed q6 mo how long to continue? Abst#1084 and less flares w Rituximab maintenance in the MAINRITSAN studies abst#527 Ritux is new SoC in GPA @RheumNow
RT @RichardPAConway: Aggarwal @docrota et al. ProDERM results on skin and QoL. Statistically significant improvements in

Richard Conway RichardPAConway

3 years 10 months ago
Aggarwal @docrota et al. ProDERM results on skin and QoL. Statistically significant improvements in CDASI (both activity and damage) and SF-36. @RheumNow #ACR22 Abstr#2239 https://t.co/vsnvYUla13
RT @RHEUMarampa: Let's review how GCs induce #Osteoporosis 👇(every Rheum should know this!)
💊GCs have bone cell sp

sheila RHEUMarampa

3 years 10 months ago
Let's review how GCs induce #Osteoporosis 👇(every Rheum should know this!) 💊GCs have bone cell specific effects on: 💠Osteoclasts ⬆️resorption, survival 💠Osteoblasts ⬇️🦴formation & prolif; ⬆️apoptosis 💠Osteocytes ⬆️apoptosis & skeletal fragility #ACR22 @RheumNow @rheumarhyme https://t.co/n61OXkmRgr
RT @RichardPAConway: Espinosa-Ortega et al. Effect of DM ab on damage (as per MDI) over time. Most damage in PM/Scl>s

Richard Conway RichardPAConway

3 years 10 months ago
Espinosa-Ortega et al. Effect of DM ab on damage (as per MDI) over time. Most damage in PM/Scl>seronegative>other abs @RheumNow #ACR22 Abstr#2241 https://t.co/g8xTRyw6NZ https://t.co/sR1tT2QmU3
RT @uptoTate: BKZ resulted in clinically meaningful improvements in FACIT-Fatigue and pain (PtAAP) in approximately half

Dr. Rachel Tate uptoTate

3 years 10 months ago
BKZ resulted in clinically meaningful improvements in FACIT-Fatigue and pain (PtAAP) in approximately half of pts w/ active PsA who are bDMARD-naïve or TNFi-IR. Abs 2119 #ACR22 @RheumNow https://t.co/29gzmMZRlG https://t.co/qziqGNxQih
RT @uptoTate: After 1st TNFi, cycling/swapping strategies both acceptable in PsA w/ similar retention rates. Further stu

Dr. Rachel Tate uptoTate

3 years 10 months ago
After 1st TNFi, cycling/swapping strategies both acceptable in PsA w/ similar retention rates. Further studies needed to perform survival subgroup analysis regarding different extra-articular manifestations and PsA subtypes. Abs 2149 #ACR22 @RheumNow https://t.co/SRPhSiGeUI https://t.co/EYDULe52A3
RT @DrTrishHarkins: 🌟 COVAX register 🌟

🦠flares of IMRD following covid vax uncommon

👉factors associated w

Patricia Harkins DrTrishHarkins

3 years 10 months ago
🌟 COVAX register 🌟 🦠flares of IMRD following covid vax uncommon 👉factors associated with flare: ⬆️disease activity 🙋‍♀️ female 💊no DMARD @ vax 💊stop/⬇️ DMARD @ vax 👉⬇️ flare assoc with: 💥young 💉RTX @RheumNow #ACR22 Abst #2274 https://t.co/S892lKcEvS
×